rAAV-delivered PTEN therapeutics for prostate cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

rAAV-delivered PTEN therapeutics for prostate cancer

Published:2022-03 Issue: Volume:27 Page:122-132
ISSN:2162-2531
Container-title:Molecular Therapy - Nucleic Acids
language:en
Short-container-title:Molecular Therapy - Nucleic Acids

Author:

Ai Jianzhong^ORCID,Li Jia,Su Qin,Ma Hong,Wei Qiang,Li Hong,Gao Guangping^ORCID

Funder

University of Massachusetts Medical School

National Natural Science Foundation of China

Department of Science and Technology of Sichuan Province

Sichuan University

Sichuan University West China Hospital

National Institutes of Health

Publisher

Elsevier BV

Subject

Drug Discovery,Molecular Medicine

Reference36 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J. Clin.,2018

2. Sipuleucel-T: immunotherapy for advanced prostate cancer;Olson;Open Access J. Urol.,2011

3. Abiraterone and increased survival in metastatic prostate cancer;de Bono;N. Engl. J. Med.,2011

4. Increased survival with enzalutamide in prostate cancer after chemotherapy;Scher;N. Engl. J. Med.,2012

5. Metastatic castration-sensitive prostate cancer: abiraterone, docetaxel, or;Barata;Cancer,2019

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DNA aptamer-conjugated lipid nanoparticle for targeted PTEN mRNA delivery to prostate cancer cells;International Journal of Pharmaceutics;2024-09

2. Gene editing therapy for cardiovascular diseases;MedComm;2024-07

3. Carbon Nanotube-Mediated Delivery of PTEN Variants: In Vitro Antitumor Activity in Breast Cancer Cells;Molecules;2024-06-11

4. Design of PD‐L1‐Targeted Lipid Nanoparticles to Turn on PTEN for Efficient Cancer Therapy;Advanced Science;2024-03-23

5. Delivery of PTEN protein into tumor cells as a promising strategy for cancer therapy via active albumin nanoparticles: A hypothesis;Medical Hypotheses;2024-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3